Hub : Traits :

Seen doctor (GP) for nerves, anxiety, tension or depression

43 significantly associated models · 20 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	1	66304567	67938108	2	1	2.9e-12	5.0e-09	0.48000	98	SGIP1
2	1	71163715	73435171	1	1	3.6e-11	6.8e-14	0.00015	74	NEGR1
3	6	147140769	148587096	1	1	6.7e-08	2.1e-06	0.64300	99	SAMD5
4	7	11553163	12967449	1	1	2.5e-10	2.4e-12	0.00161	80	TMEM106B
5	9	36590588	37277603	1	1	1.7e-07	8.9e-07	0.00962	72	PAX5
6	9	125453469	127385609	1	1	2.0e-07	1.2e-06	0.00042	47	DENND1A
7	11	65670510	67070766	1	1	1.4e-07	1.7e-07	1.00000	100	CCS
8	11	89240503	90652993	1	1	8.9e-09	1.4e-07	0.00416	70	CHORDC1
9	13	31078511	32595740	1	1	3.4e-08	7.8e-08	0.19200	94	B3GALTL
10	16	20915247	22360385	5	1	2.1e-09	1.3e-08	0.16100	94	METTL9
11	18	52209411	54028036	1	1	4.5e-08	1.1e-09	0.00083	70	TCF4
12	20	39720830	40229720	1	1	7.3e-09	7.6e-06	0.52600	98	LPIN3

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Bipolar Disorder (2018)	1.51	1	0	0.0	0.00	1.0e+00	CCS
Bipolar Disorder or Schizophrenia	2.06	1	0	0.0	0.00	1.0e+00	CCS
Depressed Affect (Nagel 2018)	5.47	5	2	4.4	0.98	3.1e-03	B3GALTL PAX5 SAMD5 TCF4 TMEM106B
Depression (Nagel 2018)	4.53	1	1	2.2	0.00	1.0e+00	TMEM106B
Intelligence (Savage-Jansen 2018)	3.77	1	1	2.2	0.00	1.0e+00	NEGR1
Neuroticism (Nagel 2018)	5.79	6	2	4.4	1.00	2.9e-05	B3GALTL CHORDC1 PAX5 SAMD5 TCF4 TMEM106B
Schizophrenia (2018)	1.74	2	0	0.0	0.00	1.0e+00	CCS PAX5
Schizophrenia vs Biploar Disorder	2.11	1	0	0.0	0.00	1.0e+00	PAX5
Worry (Nagel 2018)	4.39	6	0	0.0	1.00	2.6e-05	B3GALTL DENND1A PAX5 SAMD5 TCF4 TMEM106B
Alzheimer’s Disease (in mother)	2.55	1	0	0.0	0.00	1.0e+00	PAX5
Alzheimer’s Disease (including proxy)	2.06	1	0	0.0	0.00	1.0e+00	PAX5
Major Depression (MDD)	6.96	3	1	2.2	0.00	1.0e+00	NEGR1 TCF4 TMEM106B
Verbal and Numeric Reasoning (VNR)	3.28	1	1	2.2	0.00	1.0e+00	NEGR1
Breast Cancer	1.11	1	0	0.0	0.00	1.0e+00	NEGR1
Body Mass Index (BMI) (2010)	4.78	1	1	2.2	0.00	1.0e+00	NEGR1
LDL Cholesterol	4.74	1	1	2.2	0.00	1.0e+00	LPIN3
Neuroticism (2016)	4.03	2	0	0.0	0.00	1.0e+00	PAX5 TCF4
Schizophrenia (2014)	1.57	1	0	0.0	0.00	1.0e+00	PAX5
Blood Platelet Count	0.63	2	1	2.2	0.00	1.0e+00	LPIN3 SAMD5
Blood Red Count	0.86	2	1	2.2	0.00	1.0e+00	CCS LPIN3
Blood White Count	0.56	2	0	0.0	0.00	1.0e+00	LPIN3 SGIP1
Heel T-Score	1.59	5	3	6.7	-0.55	3.4e-01	B3GALTL CCS LPIN3 NEGR1 TCF4
BMI	3.71	5	2	4.4	0.91	2.9e-02	CCS CHORDC1 NEGR1 PAX5 TMEM106B
Height	0.84	3	3	6.7	0.00	1.0e+00	CCS TCF4 TMEM106B
Waist Hip Ratio (WHR)	1.12	1	0	0.0	0.00	1.0e+00	LPIN3
Systolic Blood Pressure	1.53	2	1	2.2	0.00	1.0e+00	B3GALTL SGIP1
Allergy or Eczema	1.63	1	0	0.0	0.00	1.0e+00	NEGR1
Cardiovascular Disease	2.44	5	1	2.2	0.97	5.0e-03	CCS NEGR1 PAX5 SGIP1 TMEM106B
Respiratory disease	2.13	2	0	0.0	0.00	1.0e+00	CCS NEGR1
Type 2 Diabetes (T2D) (2018)	1.94	1	0	0.0	0.00	1.0e+00	PAX5
Lung FEV1/FVC ratio	0.89	1	1	2.2	0.00	1.0e+00	NEGR1
Lung FVC	1.09	1	1	2.2	0.00	1.0e+00	TCF4
Neuroticism	5.95	5	2	4.4	0.98	2.7e-03	B3GALTL PAX5 SAMD5 TCF4 TMEM106B
Chronotype (morning person)	3.92	4	1	2.2	0.37	6.3e-01	DENND1A PAX5 SAMD5 TCF4
Hair Pigment	0.16	1	1	2.2	0.00	1.0e+00	DENND1A
Tanning	0.30	2	0	0.0	0.00	1.0e+00	NEGR1 TCF4
Hand grip strength (left)	2.33	2	2	4.4	0.00	1.0e+00	CCS TCF4
Number of treatments/medications taken	4.59	4	0	0.0	0.98	1.7e-02	B3GALTL CCS NEGR1 SAMD5
Frequency of depressed mood in last 2 weeks	5.56	3	0	0.0	0.00	1.0e+00	B3GALTL CHORDC1 TMEM106B
Hearing difficulty/problems: Yes	1.83	1	0	0.0	0.00	1.0e+00	CCS
Relative age of first facial hair	1.56	1	0	0.0	0.00	1.0e+00	NEGR1
Other serious medical condition/disability diagnosed by doctor	2.96	1	0	0.0	0.00	1.0e+00	NEGR1
Systolic blood pressure, automated reading	1.70	1	0	0.0	0.00	1.0e+00	SGIP1
Vitamin and mineral supplements	1.82	1	0	0.0	0.00	1.0e+00	NEGR1
Severe depression (siblings)	3.82	1	0	0.0	0.00	1.0e+00	SGIP1
Impedance of leg (right)	1.74	2	1	2.2	0.00	1.0e+00	CCS NEGR1
Leg fat-free mass (left)	0.99	2	1	2.2	0.00	1.0e+00	NEGR1 PAX5
Trunk fat percentage	1.75	2	1	2.2	0.00	1.0e+00	NEGR1 PAX5
Hand grip strength (right)	2.01	2	0	0.0	0.00	1.0e+00	CCS TCF4
Current tobacco smoking	0.98	1	0	0.0	0.00	1.0e+00	NEGR1
Fed-up feelings	3.13	2	0	0.0	0.00	1.0e+00	B3GALTL DENND1A
Frequency of unenthusiasm / disinterest in last 2 weeks	3.32	1	0	0.0	0.00	1.0e+00	TMEM106B
Taking other prescription medications	5.04	5	0	0.0	0.99	1.8e-03	CCS NEGR1 SAMD5 TCF4 TMEM106B
Age when periods started (menarche)	2.65	1	1	2.2	0.00	1.0e+00	NEGR1
High blood pressure	2.18	2	0	0.0	0.00	1.0e+00	NEGR1 PAX5
Hayfever, allergic rhinitis or eczema	1.48	1	0	0.0	0.00	1.0e+00	NEGR1
Multivitamins +/- minerals	1.77	1	0	0.0	0.00	1.0e+00	NEGR1
Stomach or abdominal pain in last month	3.36	2	0	0.0	0.00	1.0e+00	NEGR1 SGIP1
Sitting height	0.42	1	0	0.0	0.00	1.0e+00	TCF4
Body mass index (BMI)	3.16	4	2	4.4	0.95	4.7e-02	CCS NEGR1 PAX5 TMEM106B
Impedance of leg (left)	1.68	2	1	2.2	0.00	1.0e+00	CCS NEGR1
Leg predicted mass (left)	0.97	2	1	2.2	0.00	1.0e+00	NEGR1 PAX5
Trunk fat mass	1.91	2	1	2.2	0.00	1.0e+00	NEGR1 PAX5
Waist circumference	2.70	4	1	2.2	0.97	3.3e-02	DENND1A LPIN3 NEGR1 PAX5
Alcohol usually taken with meals	2.83	2	0	0.0	0.00	1.0e+00	LPIN3 NEGR1
Nervous feelings	3.67	4	0	0.0	-0.33	6.7e-01	B3GALTL METTL9 PAX5 TCF4
Frequency of tenseness / restlessness in last 2 weeks	5.58	3	0	0.0	0.00	1.0e+00	B3GALTL TCF4 TMEM106B
Hearing difficulty/problems with background noise	2.67	1	0	0.0	0.00	1.0e+00	DENND1A
Hair/balding pattern: Pattern 2	1.41	1	0	0.0	0.00	1.0e+00	LPIN3
Forced vital capacity (FVC)	1.36	1	1	2.2	0.00	1.0e+00	CCS
Qualifications: None of the above	2.49	2	1	2.2	0.00	1.0e+00	B3GALTL NEGR1
Financial difficulties in last 2 years	2.19	1	0	0.0	0.00	1.0e+00	TMEM106B
Allergy	1.89	2	0	0.0	0.00	1.0e+00	CCS NEGR1
Pain all over the body in last month	2.46	1	0	0.0	0.00	1.0e+00	SAMD5
Medication: Simvastatin	3.02	1	1	2.2	0.00	1.0e+00	LPIN3
Fluid intelligence score	2.48	1	1	2.2	0.00	1.0e+00	NEGR1
Neuroticism score	6.11	5	2	4.4	0.99	2.0e-03	B3GALTL PAX5 SAMD5 TCF4 TMEM106B
Weight	1.63	2	1	2.2	0.00	1.0e+00	NEGR1 PAX5
Impedance of arm (right)	1.32	3	1	2.2	0.00	1.0e+00	NEGR1 SAMD5 TMEM106B
Arm fat percentage (right)	2.96	3	3	6.7	0.00	1.0e+00	CCS NEGR1 PAX5
Trunk fat-free mass	0.52	1	0	0.0	0.00	1.0e+00	NEGR1
Hip circumference	1.73	2	1	2.2	0.00	1.0e+00	NEGR1 PAX5
Alcohol intake versus 10 years previously	2.54	2	0	0.0	0.00	1.0e+00	NEGR1 TMEM106B
Worrier / anxious feelings	4.63	4	1	2.2	0.97	2.8e-02	B3GALTL PAX5 TCF4 TMEM106B
Frequency of tiredness / lethargy in last 2 weeks	4.21	4	0	0.0	1.00	1.7e-03	B3GALTL CCS SAMD5 TMEM106B
Hair/balding pattern: Pattern 3	2.40	2	0	0.0	0.00	1.0e+00	LPIN3 METTL9
Forced expiratory volume in 1-second (FEV1)	1.55	1	1	2.2	0.00	1.0e+00	CCS
Qualifications: A levels/AS levels or equivalent	1.82	1	1	2.2	0.00	1.0e+00	NEGR1
Mouth/teeth dental problems: Dentures	1.63	1	0	0.0	0.00	1.0e+00	NEGR1
Asthma	1.88	1	0	0.0	0.00	1.0e+00	CCS
Medication: Cholesterol lowering	1.56	1	0	0.0	0.00	1.0e+00	LPIN3
Depression (self-reported)	5.32	2	0	0.0	0.00	1.0e+00	B3GALTL TMEM106B
Forced expiratory volume in 1-second (FEV1), Best measure	1.35	1	0	0.0	0.00	1.0e+00	CCS
Impedance of arm (left)	1.25	2	0	0.0	0.00	1.0e+00	NEGR1 TMEM106B
Arm fat mass (right)	2.73	3	2	4.4	0.00	1.0e+00	CCS NEGR1 PAX5
Trunk predicted mass	0.54	1	0	0.0	0.00	1.0e+00	NEGR1
Standing height	0.85	3	1	2.2	0.00	1.0e+00	CCS TCF4 TMEM106B
Tense / 'highly strung'	5.05	4	2	4.4	0.96	3.9e-02	B3GALTL SAMD5 SGIP1 TMEM106B
Hair/balding pattern: Pattern 4	1.80	2	0	0.0	0.00	1.0e+00	LPIN3 METTL9
Peak expiratory flow (PEF)	1.39	1	0	0.0	0.00	1.0e+00	CCS
Headache pain in last month	2.09	1	0	0.0	0.00	1.0e+00	LPIN3
Medication for cholesterol, blood pressure or diabetes	1.96	1	0	0.0	0.00	1.0e+00	NEGR1
Birth weight	1.23	1	0	0.0	0.00	1.0e+00	CCS
High blood pressure (siblings)	2.09	1	0	0.0	0.00	1.0e+00	TMEM106B
Forced vital capacity (FVC), Best measure	1.23	1	1	2.2	0.00	1.0e+00	CCS
Body fat percentage	2.33	2	1	2.2	0.00	1.0e+00	NEGR1 PAX5
Leg fat percentage (right)	2.76	3	1	2.2	0.00	1.0e+00	LPIN3 NEGR1 PAX5
Arm fat-free mass (right)	0.93	1	1	2.2	0.00	1.0e+00	NEGR1
Comparative body size at age 10	4.22	2	1	2.2	0.00	1.0e+00	B3GALTL NEGR1
Seen a psychiatrist for nerves, anxiety, tension or depression	9.43	8	0	0.0	0.99	5.1e-07	DENND1A METTL9 NEGR1 PAX5 SAMD5 SGIP1 TCF4 TMEM106B
Wheeze or whistling in the chest in last year	2.43	1	0	0.0	0.00	1.0e+00	DENND1A
Health satisfaction	2.64	1	0	0.0	0.00	1.0e+00	CCS
Shortness of breath walking on level ground	3.21	2	0	0.0	0.00	1.0e+00	CCS SGIP1
Qualifications: College or University degree	3.75	2	1	2.2	0.00	1.0e+00	B3GALTL NEGR1
Medication: Blood pressure	1.25	1	0	0.0	0.00	1.0e+00	NEGR1
Angina (self-reported)	1.95	1	0	0.0	0.00	1.0e+00	TMEM106B
Whole body fat mass	2.37	2	1	2.2	0.00	1.0e+00	NEGR1 PAX5
Leg fat mass (right)	2.83	2	1	2.2	0.00	1.0e+00	NEGR1 PAX5
Arm predicted mass (right)	0.93	1	1	2.2	0.00	1.0e+00	NEGR1
Pulse rate, automated reading	2.11	2	1	2.2	0.00	1.0e+00	NEGR1 SGIP1
Alcohol intake frequency.	4.25	4	1	2.2	0.99	7.6e-03	LPIN3 NEGR1 SGIP1 TCF4
Comparative height size at age 10	1.14	3	1	2.2	0.00	1.0e+00	CCS TCF4 TMEM106B
Suffer from 'nerves'	2.52	2	0	0.0	0.00	1.0e+00	B3GALTL TMEM106B
Overall health rating	3.70	4	0	0.0	0.98	1.8e-02	B3GALTL CCS SGIP1 TCF4
Chest pain or discomfort	3.07	1	0	0.0	0.00	1.0e+00	SAMD5
Commuting to job workplace: Car/motor vehicle	1.83	1	0	0.0	0.00	1.0e+00	NEGR1
Medication: Aspirin	1.78	1	0	0.0	0.00	1.0e+00	TMEM106B
Hypertension (Self-reported)	2.07	2	0	0.0	0.00	1.0e+00	NEGR1 PAX5
Whole body fat-free mass	0.70	2	1	2.2	0.00	1.0e+00	NEGR1 PAX5
Leg fat-free mass (right)	0.86	2	1	2.2	0.00	1.0e+00	NEGR1 PAX5
Arm fat percentage (left)	3.00	3	3	6.7	0.00	1.0e+00	CCS NEGR1 PAX5
Average weekly red wine intake	1.62	1	0	0.0	0.00	1.0e+00	NEGR1
Mood swings	6.93	4	2	4.4	0.95	5.0e-02	B3GALTL PAX5 TCF4 TMEM106B
Loneliness, isolation	3.06	2	0	0.0	0.00	1.0e+00	CHORDC1 TMEM106B
Long-standing illness, disability or infirmity	4.77	3	0	0.0	0.00	1.0e+00	DENND1A NEGR1 TMEM106B
Diabetes diagnosed by doctor	2.26	1	0	0.0	0.00	1.0e+00	PAX5
Qualifications: nursing, teaching	2.70	2	1	2.2	0.00	1.0e+00	B3GALTL NEGR1
Asthma (self-reported)	1.95	1	0	0.0	0.00	1.0e+00	CCS
Osteoporosis (self-reported)	2.00	1	0	0.0	0.00	1.0e+00	TCF4
Forced expiratory volume in 1-second (FEV1), predicted percentage	1.02	1	0	0.0	0.00	1.0e+00	DENND1A
Whole body water mass	0.71	2	1	2.2	0.00	1.0e+00	NEGR1 PAX5
Leg predicted mass (right)	0.86	2	1	2.2	0.00	1.0e+00	NEGR1 PAX5
Arm fat mass (left)	2.70	3	2	4.4	0.00	1.0e+00	CCS NEGR1 PAX5
Number of self-reported non-cancer illnesses	6.28	4	1	2.2	0.80	2.0e-01	CCS DENND1A NEGR1 TMEM106B
Miserableness	6.03	4	2	4.4	0.99	8.8e-03	B3GALTL LPIN3 TCF4 TMEM106B
Guilty feelings	4.26	2	0	0.0	0.00	1.0e+00	LPIN3 TCF4
Commuting to job workplace: Public transport	1.91	1	0	0.0	0.00	1.0e+00	NEGR1
Medication: Blood pressure	1.28	1	0	0.0	0.00	1.0e+00	PAX5
High cholesterol (Self-reported)	2.49	1	1	2.2	0.00	1.0e+00	LPIN3
Basal metabolic rate	0.90	2	1	2.2	0.00	1.0e+00	NEGR1 PAX5
Leg fat percentage (left)	2.70	2	1	2.2	0.00	1.0e+00	NEGR1 PAX5
Arm fat-free mass (left)	0.95	2	1	2.2	0.00	1.0e+00	NEGR1 PAX5
Number of operations (self-reported)	3.48	2	0	0.0	0.00	1.0e+00	NEGR1 SAMD5
Average weekly beer plus cider intake	1.34	1	0	0.0	0.00	1.0e+00	NEGR1
Irritability	4.98	4	1	2.2	1.00	7.1e-04	PAX5 SAMD5 TCF4 TMEM106B
Diastolic blood pressure, automated reading	1.52	2	0	0.0	0.00	1.0e+00	LPIN3 PAX5
Ever depressed for a whole week	3.48	1	0	0.0	0.00	1.0e+00	TMEM106B
Commuting to job workplace: Cycle	2.82	2	0	0.0	0.00	1.0e+00	NEGR1 TCF4
Vascular/heart problems diagnosed by doctor	1.96	2	0	0.0	0.00	1.0e+00	NEGR1 TMEM106B
Cholesterol lowering medication	2.81	1	1	2.2	0.00	1.0e+00	LPIN3
Medication: Omeprazole (e.g. Zanprol)	1.99	1	0	0.0	0.00	1.0e+00	SAMD5
Impedance of whole body	1.43	3	1	2.2	0.00	1.0e+00	CCS NEGR1 TMEM106B
Leg fat mass (left)	2.84	2	1	2.2	0.00	1.0e+00	NEGR1 PAX5
Arm predicted mass (left)	0.96	2	1	2.2	0.00	1.0e+00	NEGR1 PAX5

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Adipose Subcutaneous	2	0.057	1.5
GTEx	Adipose Visceral Omentum	1	0.049	1.6
GTEx	Adrenal Gland	0	0.000	1.5
GTEx	Artery Aorta	1	0.034	1.6
GTEx	Artery Coronary	0	0.000	1.6
GTEx	Artery Tibial	0	0.000	1.6
GTEx	Brain Caudate basal ganglia	0	0.000	1.5
GTEx	Brain Cerebellar Hemisphere	0	0.000	1.5
GTEx	Brain Cerebellum	0	0.000	1.6
GTEx	Brain Cortex	2	0.193	1.7
GTEx	Brain Frontal Cortex BA9	0	0.000	1.5
GTEx	Brain Hippocampus	1	0.191	1.6
GTEx	Brain Hypothalamus	0	0.000	1.5
GTEx	Brain Nucleus accumbens basal ganglia	0	0.000	1.5
GTEx	Brain Putamen basal ganglia	1	0.160	1.5
GTEx	Breast Mammary Tissue	0	0.000	1.6
GTEx	Breast Mammary Tissue (Male)	0	0.000	1.4
GTEx	Breast Mammary Tissue (Female)	0	0.000	1.6
GTEx	Cells EBV-transformed lymphocytes	1	0.070	1.6
GTEx	Cells Transformed fibroblasts	2	0.048	1.6
GTEx	Colon Sigmoid	0	0.000	1.6
GTEx	Colon Transverse	2	0.097	1.6
GTEx	Esophagus Gastroesophageal Junction	0	0.000	1.6
GTEx	Esophagus Mucosa	0	0.000	1.5
GTEx	Esophagus Muscularis	1	0.031	1.6
GTEx	Heart Atrial Appendage	0	0.000	1.6
GTEx	Heart Left Ventricle	1	0.065	1.5
GTEx	Liver	0	0.000	1.4
GTEx	Lung	3	0.104	1.6
GTEx	Muscle Skeletal	1	0.035	1.6
GTEx	Nerve Tibial	1	0.023	1.6
GTEx	Ovary	0	0.000	1.7
GTEx	Pancreas	0	0.000	1.5
GTEx	Pituitary	0	0.000	1.6
GTEx	Prostate	0	0.000	1.5
GTEx	Skin Not Sun Exposed Suprapubic	0	0.000	1.6
GTEx	Skin Sun Exposed Lower leg	1	0.027	1.5
GTEx	Small Intestine Terminal Ileum	0	0.000	1.8
GTEx	Spleen	0	0.000	1.6
GTEx	Stomach	0	0.000	1.6
GTEx	Testis	2	0.063	1.6
GTEx	Thyroid	1	0.025	1.6
GTEx	Uterus	0	0.000	1.6
GTEx	Vagina	1	0.157	1.7
GTEx	Whole Blood	1	0.050	1.5
METSIM	Adipose	0	0.000	1.5
NTR	Blood	2	0.083	1.6
ROSMAP	Brain Pre-frontal Cortex	2	0.046	1.6
YFS	Blood	1	0.022	1.5
CommonMind	Brain Pre-frontal Cortex	0	0.000	1.6
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	2	0.121	1.5
The Cancer Genome Atlas	Breast Invasive Carcinoma	1	0.023	1.5
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Colon Adenocarcinoma	0	0.000	1.5
The Cancer Genome Atlas	Esophageal Carcinoma	0	0.000	1.6
The Cancer Genome Atlas	Glioblastoma Multiforme	0	0.000	1.4
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	0	0.000	1.6
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	1	0.024	1.5
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	0	0.000	1.5
The Cancer Genome Atlas	Brain Lower Grade Glioma	0	0.000	1.4
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Lung Adenocarcinoma	2	0.068	1.6
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	2	0.080	1.5
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	0	0.000	1.5
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	2	0.120	1.6
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	0	0.000	1.4
The Cancer Genome Atlas	Prostate Adenocarcinoma	1	0.022	1.5
The Cancer Genome Atlas	Rectum Adenocarcinoma	0	0.000	1.5
The Cancer Genome Atlas	Soft Tissue Sarcoma	0	0.000	1.5
The Cancer Genome Atlas	Skin Cutaneous Melanoma	0	0.000	1.5
The Cancer Genome Atlas	Stomach Adenocarcinoma	0	0.000	1.6
The Cancer Genome Atlas	Testicular Germ Cell Tumors	0	0.000	1.5
The Cancer Genome Atlas	Thyroid Carcinoma	1	0.019	1.5
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	0	0.000	1.5